Citations

Citations to this article as recorded by  

• Neoadjuvant Immunotherapy in Gastroesophageal Cancer: A Promising Early Signal?
  Mojun Zhu, Harry H. Yoon
  Journal of Clinical Oncology.2024; 42(4): 373.     CrossRef
• Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, C
  Dordi Lea, Claudia Zaharia, Kjetil Søreide
  Cancer Treatment and Research Communications.2024; 38: 100788.     CrossRef
• The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study
  Jeffry Beta Tenggara, Andhika Rachman, Joedo Prihartono, Lisnawati Rachmadi, Sonar Soni Panigoro, Didik Setyo Heriyanto, Noorwati Sutandyo, Intan Russianna Nasution, Familia Bella Rahadiati, Ricci Steven, Rachelle Betsy, Samuel Juanputra, Aru Wisaksono Su
  BMC Research Notes.2024;[Epub]     CrossRef
• Who Should Receive Immunotherapy for Advanced Gastroesophageal Cancer?
  Suhaib Khateeb, Ludimila Cavalcante, Noor Alnairat, Meghana Singh, Ibrahim Halil Sahin, Azhar Saeed, Anwaar Saeed
  Current Treatment Options in Oncology.2024; 25(4): 496.     CrossRef
• Evaluation of PD-L1 Expression in Colorectal Carcinomas by Comparing Scoring Methods and Their Significance in Relation to Clinicopathologic Parameters
  Mirela Frančina, Mislav Mikuš, Marin Mamić, Tihomir Jovanović, Mario Ćorić, Božica Lovrić, Ivan Vukoja, Goran Zukanović, Kristijan Matković, Jasmina Rajc, Ferdinand Slišurić, Mateja Jurić-Marelja, Goran Augustin, Ilijan Tomaš
  Diagnostics.2024; 14(10): 1007.     CrossRef
• The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review
  J. Bos, T.S. Groen-van Schooten, C.P. Brugman, F.S. Jamaludin, H.W.M. van Laarhoven, S. Derks
  Cancer Treatment Reviews.2024; 127: 102737.     CrossRef
• Discordant PD-L1 results between 28–8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy
  Hyung-Don Kim, Jinho Shin, In Hye Song, Jaewon Hyung, Hyungeun Lee, Min-Hee Ryu, Young Soo Park
  Gastric Cancer.2024; 27(4): 819.     CrossRef
• Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination
  Haruki Ogawa, Hiroyuki Abe, Koichi Yagi, Yasuyuki Seto, Tetsuo Ushiku
  Gastric Cancer.2024; 27(4): 802.     CrossRef
• Interpretation of PD-L1 expression in gastric cancer: summary of a consensus meeting of Korean gastrointestinal pathologists
  Soomin Ahn, Yoonjin Kwak, Gui Young Kwon, Kyoung-Mee Kim, Moonsik Kim, Hyunki Kim, Young Soo Park, Hyeon Jeong Oh, Kyoungyul Lee, Sung Hak Lee, Hye Seung Lee
  Journal of Pathology and Translational Medicine.2024; 58(3): 103.     CrossRef
• PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays
  Samuel J. Klempner, Eric S. Cowden, Samuel L. Cytryn, Matteo Fassan, Hisato Kawakami, Hideaki Shimada, Laura H. Tang, Daniel-Christoph Wagner, Yasushi Yatabe, Alexander Savchenko, Jennifer Salcius, Dorhyun Johng, Jing Chen, Giuliana Montenegro, Markus Moe
  JCO Precision Oncology.2024;[Epub]     CrossRef
• PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV
  Lucília Lovane, Satish Tulsidás, Carla Carrilho, Christina Karlsson
  Scientific Reports.2024;[Epub]     CrossRef
• First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population
  Feiyang Zhang, Guoming Chen, Yixin Yin, Xiaojiang Chen, Runcong Nie, Yingbo Chen
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Concordance of PD-L1 status in primary gastroesophageal adenocarcinoma and matched peritoneal metastases: a single institution study
  V. Massa, F. Signorini, F. Salani, M.E. Filice, G. Grelli, P. Lippolis, P. Faviana, V. Genovesi, S. Santi, C. Vivaldi, S. Cesario, A. Bertolucci, C. Cremolini, V. Nardini, G. Masi, C. Ugolini, L. Fornaro
  ESMO Gastrointestinal Oncology.2024; 5: 100089.     CrossRef
• A Phase 1a/1b Dose Escalation/Expansion Study of the Anti-PD-1 Monoclonal Antibody Nofazinlimab in Chinese Patients with Solid Tumors or Lymphoma
  Jifang Gong, Ye Guo, Yanqiao Zhang, Yi Ba, Tong Chen, Wei Li, Caicun Zhou, Mengzhao Wang, Haiyan Yang, Yuhong Zhou, Qiqing Cai, Ziping Wang, Gang Huang, Wei Zhang, Rila Su, Zhongheng Cai, Zenglian Yue, Jinzhou Dou, Peiqi Li, Rachel Wu, Archie N. Tse, Lin
  Targeted Oncology.2024; 19(5): 723.     CrossRef
• Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroups
  A.G. Leone, A.S. Mai, K.Y. Fong, D.W.T. Yap, K. Kato, E. Smyth, M. Moehler, J.T.C. Seong, R. Sundar, J.J. Zhao, F. Pietrantonio
  ESMO Open.2024; 9(11): 103962.     CrossRef
• HIPEC for Metastatic Gastric Cancer: Moving the Needle Towards 3-Year Survival
  Neal Bhutiani, Y. David Seo, Kristen A. Robinson, Michael G. White, Naruhiko Ikoma, Paul F. Mansfield, Jenny J. Li, Mariela Blum Murphy, Jaffer A. Ajani, Brian D. Badgwell
  European Journal of Surgical Oncology.2024; : 108790.     CrossRef
• Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
  Moonsik Kim, Ji Yun Jeong, An Na Seo
  Diagnostics.2023; 13(17): 2782.     CrossRef
• Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images
  Abhishek Vahadane, Shreya Sharma, Devraj Mandal, Madan Dabbeeru, Josephine Jakthong, Miguel Garcia-Guzman, Shantanu Majumdar, Chung-Wein Lee
  Computers in Biology and Medicine.2023; 152: 106337.     CrossRef
• CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
  Jiazheng Li, Zifan Chen, Yang Chen, Jie Zhao, Meng He, Xiaoting Li, Li Zhang, Bin Dong, Xiaotian Zhang, Lei Tang, Lin Shen
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis
  Gengwei Huo, Wenjie Liu, Peng Chen
  BMC Cancer.2023;[Epub]     CrossRef
• Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
  Joan Choo, Ley Fang Kua, Mu Yar Soe, Bernadette Reyna Asuncion, Benjamin Kye Jyn Tan, Chong Boon Teo, Ryan Yong Kiat Tay, Jimmy So, Asim Shabbir, Kim Guowei, Hon Lyn Tan, Gloria Chan, Haoran Ma, Gokula Krishnan Ramachandran, Jeffrey H. Y. Lum, Cheng Ean C
  Gastric Cancer.2023; 26(3): 393.     CrossRef
• Genetic and immune microenvironment characterization of HER2‐positive gastric cancer: Their association with response to trastuzumab‐based treatment
  Hyun Jung Kwon, Yujun Park, Soo Kyung Nam, Enoch Kang, Ka‐Kyung Kim, Inhae Jeong, Yoonjin Kwak, Jeesun Yoon, Tae‐Yong Kim, Keun‐Wook Lee, Do‐Youn Oh, Seock‐Ah Im, Seong‐Ho Kong, Do Joong Park, Hyuk‐Joon Lee, Hyung‐Ho Kim, Han‐Kwang Yang, Hye Seung Lee
  Cancer Medicine.2023; 12(9): 10371.     CrossRef
• High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma
  Marie E. Robert, Josef Rüschoff, Bharat Jasani, Rondell P. Graham, Sunil S. Badve, Manuel Rodriguez-Justo, Liudmila L. Kodach, Amitabh Srivastava, Hanlin L. Wang, Laura H. Tang, Giancarlo Troncone, Federico Rojo, Benjamin J. Van Treeck, James Pratt, Iryna
  Modern Pathology.2023; 36(5): 100154.     CrossRef
• Heterogeneous distribution pattern of CD3+ tumor-infiltrated lymphocytes (TILs) and high combined positive score (CPS) favored the prognosis of resected early stage small-cell lung cancer
  Liang Zhu, Guoping Cheng, Meijuan Wu, Ming Chen, Ying Jin
  Translational Oncology.2023; 34: 101697.     CrossRef
• The Role of Immunotherapy in Esophageal and Gastric Cancer
  Hans Dedecker, Laure-Anne Teuwen, Timon Vandamme, Andreas Domen, Hans Prenen
  Clinical Colorectal Cancer.2023; 22(2): 175.     CrossRef
• Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer
  Luca Licata, Marco Mariani, Federico Rossari, Giulia Viale, Giulia Notini, Matteo Maria Naldini, Carlo Bosi, Marta Piras, Matteo Dugo, Giampaolo Bianchini
  The Breast.2023; 69: 330.     CrossRef
• PD‐L1andHLA‐class I expression status and their therapeutic implication in oesophageal small‐cell carcinoma
  Satoshi Yamashita, Hiroyuki Abe, Hiroharu Yamashita, Koichi Yagi, Yasuyuki Seto, Tetsuo Ushiku
  Histopathology.2023; 83(2): 264.     CrossRef
• Programmed death-ligand 1 expression and overall survival in Thai patients with gastric cancer
  Taned Chitapanarux, Pawut Gumrai, Sarawut Kongkarnka, Komson Wannasai, Nirush Lertprasertsuke
  Scientific Reports.2023;[Epub]     CrossRef
• Efficacy of Pd-1/Pd-L1 Inhibitors in Advanced Gastroesophageal Cancer Based on Characteristics: A Meta-Analysis
  Wenjie Liu, Gengwei Huo, Peng Chen
  Immunotherapy.2023; 15(10): 751.     CrossRef
• Immunology and immunotherapy in gastric cancer
  Xiaqing Xu, Jiaxing Chen, Wenxing Li, Chenlu Feng, Qian Liu, Wenfang Gao, Meng He
  Clinical and Experimental Medicine.2023; 23(7): 3189.     CrossRef
• Targeted Therapies and Developing Precision Medicine in Gastric Cancer
  Rille Pihlak, Caroline Fong, Naureen Starling
  Cancers.2023; 15(12): 3248.     CrossRef
• Programmed death ligand 1 (PD-L1) expression in gastric cancer: literature review
  T. N. Sotnikova, N. V. Danilova, P. G. Malkov, T. V. Polushkina
  Advances in Molecular Oncology.2023; 10(2): 70.     CrossRef
• Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
  Yasushi Sato, Koichi Okamoto, Yutaka Kawano, Akinari Kasai, Tomoyuki Kawaguchi, Tamotsu Sagawa, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama
  Journal of Clinical Medicine.2023; 12(14): 4646.     CrossRef
• Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
  Drolaiz H. W. Liu, Heike I. Grabsch, Beat Gloor, Rupert Langer, Bastian Dislich
  Journal of Cancer Research and Clinical Oncology.2023; 149(14): 13345.     CrossRef
• Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials
  Zhen Zhang, Jiaqian Huang, Yuhong Xu, Huiyan Luo
  MedComm – Future Medicine.2023;[Epub]     CrossRef
• Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?
  Hassan Abushukair, Obada Ababneh, Ayah Al-Bzour, Ibrahim Halil Sahin, Anwaar Saeed
  Expert Review of Molecular Diagnostics.2023; 23(10): 863.     CrossRef
• Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer
  Minkyue Shin, Soomin Ahn, Jaeyun Jung, Sujin Hyung, Kyoung‐Mee Kim, Seung Tae Kim, Won Ki Kang, Jeeyun Lee
  Cancer Medicine.2023; 12(18): 18633.     CrossRef
• Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
  Ion Negura, Mariana Pavel-Tanasa, Mihai Danciu
  Cancer Treatment Reviews.2023; 120: 102629.     CrossRef
• The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
  Ji Eun Choi, Jae Seok Lee, Min-Sun Jin, Ilias P. Nikas, Kwangsoo Kim, Sunah Yang, Soo Young Park, Jiwon Koh, Sohyeon Yang, Seock-Ah Im, Han Suk Ryu
  Breast Cancer Research.2023;[Epub]     CrossRef
• Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial
  Shirish Gadgeel, Fred R. Hirsch, Keith Kerr, Fabrice Barlesi, Keunchil Park, Achim Rittmeyer, Wei Zou, Namrata Bhatia, Hartmut Koeppen, Sarah M. Paul, David Shames, Jing Yi, Christina Matheny, Marcus Ballinger, Mark McCleland, David R. Gandara
  Clinical Lung Cancer.2022; 23(1): 21.     CrossRef
• Adrenal Nodules Detected at Staging CT in Patients with Resectable Gastric Cancers Have a Low Incidence of Malignancy
  Hae Young Kim, Won Chang, Yoon Jin Lee, Ji Hoon Park, Jungheum Cho, Hee Young Na, Hyungwoo Ahn, Sung Il Hwang, Hak Jong Lee, Young Hoon Kim, Kyoung Ho Lee
  Radiology.2022; 302(1): 129.     CrossRef
• Immunohistochemistry as predictive and prognostic markers for gastrointestinal malignancies
  Matthew W. Rosenbaum, Raul S. Gonzalez
  Seminars in Diagnostic Pathology.2022; 39(1): 48.     CrossRef
• Histopathology of Gastrointestinal Immune-related Adverse Events
  M. Lisa Zhang, Vikram Deshpande
  American Journal of Surgical Pathology.2022; 46(1): e15.     CrossRef
• Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
  D.V.T. Catenacci, H.C. Chung, L. Shen, M. Moehler, H.H. Yoon, M.K. Rosales, Y.-K. Kang
  ESMO Open.2022; 7(1): 100360.     CrossRef
• PD-L1 and HER2 expression in gastric adenocarcinoma and their prognostic significance
  Jie Lian, Guanjun Zhang, Yun Zhang, Heng Liu, Jiaojiao Zhang, Pengfei Nan, Wei Tian
  Digestive and Liver Disease.2022; 54(10): 1419.     CrossRef
• Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer
  Enoch Kang, Sung Cheol Jung, Soo Kyung Nam, Yujun Park, Soo Hyun Seo, Kyoung Un Park, Heung-Kwon Oh, Duck-Woo Kim, Sung-Bum Kang, Hye Seung Lee
  Scientific Reports.2022;[Epub]     CrossRef
• Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
  Sangjoon Choi, Sujin Park, Hyunjin Kim, So Young Kang, Soomin Ahn, Kyoung-Mee Kim
  Biomedicines.2022; 10(3): 543.     CrossRef
• Immunotherapy use in oesophagogastric cancers—a review of the literature
  Annabel Smith, Amitesh Roy, Christos S. Karapetis, Vy Broadbridge, Timothy Price
  British Journal of Cancer.2022; 127(1): 21.     CrossRef
• Interspatial Distribution of Tumor and Immune Cells in Correlation with PD-L1 in Molecular Subtypes of Gastric Cancers
  Bastian Dislich, Kirsten D. Mertz, Beat Gloor, Rupert Langer
  Cancers.2022; 14(7): 1736.     CrossRef
• Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy
  Mary E. Booth, Elizabeth C. Smyth
  BioDrugs.2022; 36(4): 473.     CrossRef
• Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma
  Man Jiang, Chuantao Zhang, Yabin Hu, Tianjun Li, Guangjie Yang, Guanqun Wang, Jingjuan Zhu, Changfeng Shao, Helei Hou, Na Zhou, Kewei Liu, Xiaochun Zhang
  The Oncologist.2022; 27(11): e856.     CrossRef
• Abdominal Computed Tomography Enhanced Image Features under an Automatic Segmentation Algorithm in Identification of Gastric Cancer and Gastric Lymphoma
  Lihua Zhou, Hao Hu, Lei Zhou, Yi Zhou, Ahmed Faeq Hussein
  Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
• Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
  D.V.T. Catenacci, Y.-K. Kang, H.H. Yoon, B.Y. Shim, S.T. Kim, D.-Y. Oh, A.I. Spira, S.V. Ulahannan, E.J. Avery, P.M. Boland, J. Chao, H.C. Chung, F. Gardner, S.J. Klempner, K.-W. Lee, S.C. Oh, J. Peguero, M.B. Sonbol, L. Shen, M. Moehler, J. Sun, D. Li, M
  ESMO Open.2022; 7(5): 100563.     CrossRef
• Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy
  Hongzhen Cai, Man Li, Ruiyi Deng, Mopei Wang, Yanyan Shi
  Biomarker Research.2022;[Epub]     CrossRef
• Immune Checkpoint Inhibitors for Gastrointestinal Malignancies: An Update
  Kathryn DeCarli, Jonathan Strosberg, Khaldoun Almhanna
  Cancers.2022; 14(17): 4201.     CrossRef
• Immunotherapy for Gastroesophageal Tumors: Is there still Hope for Efficacy?
  Hannah Christina Puhr, Aysegul Ilhan-Mutlu
  Current Cancer Drug Targets.2022; 22(8): 651.     CrossRef
• The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers
  Corina-Elena Minciuna, Mihai Tanase, Teodora Ecaterina Manuc, Stefan Tudor, Vlad Herlea, Mihnea P. Dragomir, George A. Calin, Catalin Vasilescu
  Computational and Structural Biotechnology Journal.2022; 20: 5065.     CrossRef
• Ornithine aminotransferase and carbamoyl phosphate synthetase 1 involved in ammonia metabolism serve as novel targets for early stages of gastric cancer
  Zhen Jiang, Chen Wei, Yaomin Luo, Yang Xiao, Li Wang, Wubin Guo, Xiaoxia Yuan
  Journal of Clinical Laboratory Analysis.2022;[Epub]     CrossRef
• Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate
  Ji Min Kim, Binnari Kim, Eunji Kim, Minsun Jang, Jun Hun Cho, Hye Seung Lee, Yoonjin Kwak, Lingkang Huang, Radha Krishnan, Sally Y. Bai, Mounia Mounawar, Kyoung-Mee Kim
  Molecular Diagnosis & Therapy.2022; 26(6): 679.     CrossRef
• High interobserver and intraobserver reproducibility among pathologists assessing PD‐L1 CPS across multiple indications
  Shanthy Nuti, Yiwei Zhang, Nabila Zerrouki, Charlotte Roach, Gudrun Bänfer, George L Kumar, Edward Manna, Rolf Diezko, Kristopher Kersch, Josef Rüschoff, Bharat Jasani
  Histopathology.2022; 81(6): 732.     CrossRef
• Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer
  Lianxi Song, Liang Zeng, Huan Yan, Qinqin Xu, Qing Xia, Jian Lei, Xiaoyan Chen, Xiaoping Hu, Zhan Wang, Hong Liu, Nong Yang, Yongchang Zhang
  Communications Medicine.2022;[Epub]     CrossRef
• Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer
  Jan Hrudka, Radoslav Matěj, Andrej Nikov, Igor Tomyak, Hana Fišerová, Karolína Jelínková, Petr Waldauf
  Scientific Reports.2022;[Epub]     CrossRef
• Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma
  Satoshi Yamashita, Hiroyuki Abe, Akiko Kunita, Hiroharu Yamashita, Yasuyuki Seto, Tetsuo Ushiku
  Histopathology.2021; 78(3): 381.     CrossRef
• MAHOGANY: Margetuximab Combination in HER2+ Unresectable/metastatic Gastric/gastroesophageal Junction Adenocarcinoma
  Daniel V T Catenacci, Minori Rosales, Hyun Cheol Chung, Harry H Yoon, Lin Shen, Markus Moehler, Yoon-Koo Kang
  Future Oncology.2021; 17(10): 1155.     CrossRef
• PD-L1 expression in paired biopsies and surgical specimens in gastric adenocarcinoma: A digital image analysis study
  You Jeong Heo, Binnari Kim, Hyunjin Kim, Soi Kim, Min Sun Jang, Kyoung-Mee Kim
  Pathology - Research and Practice.2021; 218: 153338.     CrossRef
• Targeting Oncoimmune Drivers of Cancer Metastasis
  Chie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, Hideyuki Hayashi, Jun Masuda, Hiroki Ozawa, Yamato Ogiwara
  Cancers.2021; 13(3): 554.     CrossRef
• PD-L1 as a biomarker of response to immune-checkpoint inhibitors
  Deborah Blythe Doroshow, Sheena Bhalla, Mary Beth Beasley, Lynette M. Sholl, Keith M. Kerr, Sacha Gnjatic, Ignacio I. Wistuba, David L. Rimm, Ming Sound Tsao, Fred R. Hirsch
  Nature Reviews Clinical Oncology.2021; 18(6): 345.     CrossRef
• Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
  Julianne D. Twomey, Baolin Zhang
  The AAPS Journal.2021;[Epub]     CrossRef
• High Expression of PD-L1 Is Associated with Better Survival in Pancreatic/Periampullary Cancers and Correlates with Epithelial to Mesenchymal Transition
  Nishant Thakur, Kwang Yeol Paik, Gyoyeon Hwang, Yosep Chong
  Diagnostics.2021; 11(4): 597.     CrossRef
• Prädiktive Diagnostik für Checkpoint-Inhibitoren
  Hans-Ulrich Schildhaus, Wilko Weichert
  Der Pathologe.2021; 42(4): 380.     CrossRef
• PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
  Enrico Munari, Francesca R. Mariotti, Linda Quatrini, Pietro Bertoglio, Nicola Tumino, Paola Vacca, Albino Eccher, Francesco Ciompi, Matteo Brunelli, Guido Martignoni, Giuseppe Bogina, Lorenzo Moretta
  International Journal of Molecular Sciences.2021; 22(10): 5123.     CrossRef
• PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy
  Soomin Ahn, Kyoung-Mee Kim
  Modern Pathology.2021; 34(9): 1719.     CrossRef
• PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 Assays
  Tamara Z. Dabbagh, Maher A. Sughayer
  Applied Immunohistochemistry & Molecular Morphology.2021; 29(6): 462.     CrossRef
• Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
  Yujun Park, An Na Seo, Jiwon Koh, Soo Kyoung Nam, Yoonjin Kwak, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
  OncoImmunology.2021;[Epub]     CrossRef
• Appropriate PD-L1 Cutoff Value for Gastric Cancer Immunotherapy: A Systematic Review and Meta-Analysis
  Tong Xie, Zhening Zhang, Xiaotian Zhang, Changsong Qi, Lin Shen, Zhi Peng
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
  Hye Jung Hwang, Soo Kyung Nam, Hyunjin Park, Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Woo Ho Kim, Hye Seung Lee
  Journal of Pathology and Translational Medicine.2020; 54(5): 378.     CrossRef

Citations

Citations to this article as recorded by  

• Sex Difference of Colon Adenoma Pathway and Colorectal Carcinogenesis
  Yonghoon Choi, Nayoung Kim
  The World Journal of Men's Health.2024; 42(2): 256.     CrossRef
• Sex differences in colorectal cancer: with a focus on sex hormone–gut microbiome axis
  Zihong Wu, Yuqing Huang, Renyi Zhang, Chuan Zheng, Fengming You, Min Wang, Chong Xiao, Xueke Li
  Cell Communication and Signaling.2024;[Epub]     CrossRef
• Gα12 and endoplasmic reticulum stress-mediated pyroptosis in a single cycle of dextran sulfate-induced mouse colitis
  Jihoon Tak, Quanxi An, Sang Gil Lee, Chang Hoon Lee, Sang Geon Kim
  Scientific Reports.2024;[Epub]     CrossRef
• Sexual dimorphism in colorectal cancer: molecular mechanisms and treatment strategies
  Yair Rodríguez-Santiago, Claudia Angelica Garay-Canales, Karen Elizabeth Nava-Castro, Jorge Morales-Montor
  Biology of Sex Differences.2024;[Epub]     CrossRef
• 17β-estradiol in colorectal cancer: friend or foe?
  Zihong Wu, Chong Xiao, Jiamei Wang, Min Zhou, Fengming You, Xueke Li
  Cell Communication and Signaling.2024;[Epub]     CrossRef
• Sexual dimorphism of colorectal cancer in humans and colorectal tumors in a murine model
  Yair Rodríguez-Santiago, Luis Ignacio Terrazas-Valdés, Karen Elizabeth Nava-Castro, Víctor Hugo Del Río-Araiza, Claudia Angélica Garay-Canales, Jorge Morales-Montor
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Sex difference in human diseases: mechanistic insights and clinical implications
  Yuncong Shi, Jianshuai Ma, Sijin Li, Chao Liu, Yuning Liu, Jie Chen, Ningning Liu, Shiming Liu, Hui Huang
  Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
• Tocotrienol suppresses colitis-associated cancer progression through TLR4 signaling in a mouse model of colorectal cancer
  Qian Li, Shujing Zhang, Qinghong Zhou, Chenxi Gu, Yinghua Liu, Jing Zhang, Jingshu Zhang
  Current Research in Toxicology.2024; 7: 100196.     CrossRef
• Ninjurin1 deficiency differentially mitigates colorectal cancer induced by azoxymethane and dextran sulfate sodium in male and female mice
  Chin‐Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Eun Hye Kim, Sungchan Ha, Eun Shin, Hoon Choi, Kyu‐Won Kim, Sejin Jeon, Goo Taeg Oh, Yeong‐Jae Seok
  International Journal of Cancer.2024;[Epub]     CrossRef
• Sexual dimorphism of gut microbiota in colorectal cancer
  Zihong Wu, Ziming Wang, Jiamei Wang, Chong Xiao, Fengming You, Xueke Li
  Chinese Science Bulletin.2024;[Epub]     CrossRef
• Direct and indirect effects of estrogens, androgens and intestinal microbiota on colorectal cancer
  Zihong Wu, Yi Sun, Wenbo Huang, Zhenzhen Jin, Fengming You, Xueke Li, Chong Xiao
  Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
• Estrogen-related differences in antitumor immunity and gut microbiome contribute to sexual dimorphism of colorectal cancer
  Georgia Lattanzi, Federica Perillo, Angélica Díaz-Basabe, Bruna Caridi, Chiara Amoroso, Alberto Baeri, Elisa Cirrincione, Michele Ghidini, Barbara Galassi, Elisa Cassinotti, Ludovica Baldari, Luigi Boni, Maurizio Vecchi, Flavio Caprioli, Federica Facciott
  OncoImmunology.2024;[Epub]     CrossRef
• Characteristic submucosal alteration in biliary carcinogenesis of pancreaticobiliary maljunction with a focus on inflammasome activation
  Shoko Yamashita, Chie Takasu, Yuji Morine, Hiroki Ishibashi, Tetsuya Ikemoto, Hiroki Mori, Shinichiro Yamada, Takeshi Oya, Koichi Tsuneyama, Mitsuo Shimada
  Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(4): 462.     CrossRef
• Changes in Gut Microbiome upon Orchiectomy and Testosterone Administration in AOM/DSS-Induced Colon Cancer Mouse Model
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Ha-Na Lee
  Cancer Research and Treatment.2023; 55(1): 196.     CrossRef
• Influence of location-dependent sex difference on PD-L1, MMR/MSI, and EGFR in colorectal carcinogenesis
  Jina Choi, Nayoung Kim, Ryoung Hee Nam, Jin Won Kim, Chin-Hee Song, Hee Young Na, Gyeong Hoon Kang, Alvaro Galli
  PLOS ONE.2023; 18(2): e0282017.     CrossRef
• Anti–PD-L1 Antibody and/or 17β-Estradiol Treatment Induces Changes in the Gut Microbiome in MC38 Colon Tumor Model
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Jina Choi, Ha-Na Lee
  Cancer Research and Treatment.2023; 55(3): 894.     CrossRef
• The influence of COVID-19 on colorectal cancer was investigated using bioinformatics and systems biology techniques
  Yujia Song, Tengda Huang, Hongyuan Pan, Ao Du, Tian Wu, Jiang Lan, Xinyi Zhou, Yue Lv, Shuai Xue, Kefei Yuan
  Frontiers in Medicine.2023;[Epub]     CrossRef
• ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer
  Cheng Zuo, Yong-sheng Xu, Peng-fei He, Wen-jun Zhang
  European Journal of Medicinal Chemistry.2023; 261: 115877.     CrossRef
• Estrogen plays an important role by influencing the NLRP3 inflammasome
  Wanglin Dong, Qianwen Peng, Zhuoxin Liu, Zhenxing Xie, Xiajun Guo, Yuanyuan Li, Chaoran Chen
  Biomedicine & Pharmacotherapy.2023; 167: 115554.     CrossRef
• NOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers
  Yujie Zhou, Songyan Yu, Wenyong Zhang
  International Journal of Molecular Sciences.2023; 24(19): 14511.     CrossRef
• Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment
  Liu Wenxuan, Li Liu, Lilong Zhang, Zhendong Qiu, Zhongkai Wu, Wenhong Deng
  Frontiers in Oncology.2023;[Epub]     CrossRef
• A novel targeted approach to delineate a role for estrogen receptor-β in ameliorating murine mammary tumor-associated neuroinflammation
  Corena V. Grant, Kathryn L. G. Russart, Leah M. Pyter
  Endocrine.2022; 75(3): 949.     CrossRef
• Association of Type 1 diabetes with ulcerative colitis in BALB/c mice: Investigations on sex‐specific differences
  Shivani Singla, Chittaranjan Sahu, Gopabandhu Jena
  Journal of Biochemical and Molecular Toxicology.2022;[Epub]     CrossRef
• Lactobacillus paracasei BD5115-Derived 2-Hydroxy-3-Methylbutyric Acid Promotes Intestinal Epithelial Cells Proliferation by Upregulating the MYC Signaling Pathway
  Zhenyi Qiao, Xiaohua Wang, Chaoyue Wang, Jin Han, Weiwei Qi, Huanchang Zhang, Zhenmin Liu, Chunping You
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Jin Won Kim, Hee Young Na, Ha-Na Lee
  Cancer Letters.2022; 543: 215780.     CrossRef
• Sex/Gender-related Differences in Reflux Esophagitis and Peptic Ulcer Disease in Terms of Sex Hormones
  Nayoung Kim
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(2): 157.     CrossRef
• Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD)
  Shi-Tao Jiang, Yao-Ge Liu, Lei Zhang, Xin-Ting Sang, Yi-Yao Xu, Xin Lu
  European Journal of Medical Research.2022;[Epub]     CrossRef
• Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms
  Suhuan Mei, Haile Ma, Xiumin Chen
  Food and Chemical Toxicology.2021; 149: 111997.     CrossRef
• Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
  Emiliano Panieri, Luciano Saso
  Antioxidants & Redox Signaling.2021; 34(18): 1428.     CrossRef
• Endogenous sex steroid hormones and colorectal cancer risk: a systematic review and meta-analysis
  Emmanouil Bouras, Christopher Papandreou, Ioanna Tzoulaki, Konstantinos K. Tsilidis
  Discover Oncology.2021;[Epub]     CrossRef
• Nuclear Factor Erythroid 2-related Factor 2 Knockout Suppresses the Development of Aggressive Colorectal Cancer Formation Induced by Azoxymethane/Dextran Sulfate Sodium-Treatment in Female Mice
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Changhee Kang, Jae Young Jang, Heewon Nho, Eun Shin, Ha-Na Lee
  Journal of Cancer Prevention.2021; 26(1): 41.     CrossRef
• Changes in Microbial Community Composition Related to Sex and Colon Cancer by Nrf2 Knockout
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jeong Eun Yu, Heewon Nho, Young-Joon Surh
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• The Enhanced Inhibitory Effect of Estrogen on PD-L1 Expression Following Nrf2 Deficiency in the AOM/DSS Model of Colitis-Associated Cancer
  Changhee Kang, Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jeong Eun Yu, Heewon Nho, Jin A. Choi, Jin Won Kim, Hee Young Na, Ha-Na Lee, Young-Joon Surh
  Frontiers in Oncology.2021;[Epub]     CrossRef
• The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses
  Kayla Jaye, Chun Guang Li, Deep Jyoti Bhuyan
  Critical Reviews in Oncology/Hematology.2021; 165: 103429.     CrossRef
• Sex- and Gender-related Issues of Gut Microbiota in Gastrointestinal Tract Diseases
  Nayoung Kim
  The Korean Journal of Gastroenterology.2021; 78(1): 9.     CrossRef
• Estrogen Receptors in Colorectal Cancer: Facts, Novelties and Perspectives
  Ilaria Ditonno, Giuseppe Losurdo, Maria Rendina, Maria Pricci, Bruna Girardi, Enzo Ierardi, Alfredo Di Leo
  Current Oncology.2021; 28(6): 4256.     CrossRef
• Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex
  Ju Yup Lee, Nayoung Kim, Ji Hyun Park, Ryoung Hee Nam, Sun Min Lee, Chin-Hee Song, Geun Kim, Hee Young Na, Yoon Jin Choi, Jin Joo Kim, Dong Ho Lee
  Journal of Neurogastroenterology and Motility.2020; 26(1): 106.     CrossRef
• Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes
  Linnea Hases, Rajitha Indukuri, Madeleine Birgersson, Trang Nguyen-Vu, Rodrigo Lozano, Ashish Saxena, Johan Hartman, Jonna Frasor, Jan-Åke Gustafsson, Pekka Katajisto, Amena Archer, Cecilia Williams
  Cancer Letters.2020; 492: 54.     CrossRef
• 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Ha-Na Lee, Young-Joon Surh
  Scientific Reports.2020;[Epub]     CrossRef
• A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
  Haitao Chen, Fan Zhang, Jin Zhang, Xinjie Zhang, Yong Guo, Qinghua Yao
  Frontiers in Immunology.2020;[Epub]     CrossRef
• High-fat diet and estrogen impacts the colon and its transcriptome in a sex-dependent manner
  L. Hases, A. Archer, R. Indukuri, M. Birgersson, C. Savva, M. Korach-André, C. Williams
  Scientific Reports.2020;[Epub]     CrossRef
• 17β-Estradiol strongly inhibits azoxymethane/dextran sulfate sodium-induced colorectal cancer development in Nrf2 knockout male mice
  Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Joo Hee Son, Jeong Eun Yu, Eun Shin, Ha-Na Lee, Do-Hee Kim, Young-Joon Surh
  Biochemical Pharmacology.2020; 182: 114279.     CrossRef
• Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
  Katie Lloyd, Stamatia Papoutsopoulou, Emily Smith, Philip Stegmaier, Francois Bergey, Lorna Morris, Madeleine Kittner, Hazel England, Dave Spiller, Mike H. R. White, Carrie A. Duckworth, Barry J. Campbell, Vladimir Poroikov, Vitor A. P. Martins dos Santos
  Disease Models & Mechanisms.2020;[Epub]     CrossRef
• Effects of 17β-Estradiol on Colorectal Cancer Development after Azoxymethane/Dextran Sulfate Sodium Treatment of Ovariectomized Mice
  Chin-Hee Song, Nayoung Kim, Sun Min Lee, Ryoung Hee Nam, Soo In Choi, So Ra Kang, Eun Shin, Dong Ho Lee, Ha-Na Lee, Young-Joon Surh
  Biochemical Pharmacology.2019;[Epub]     CrossRef
• 17-β estradiol exerts anti-inflammatory effects through activation of Nrf2 in mouse embryonic fibroblasts
  Chin-Hee Song, Nayoung Kim, Do-Hee Kim, Ha-Na Lee, Young-Joon Surh, Seungil Ro
  PLOS ONE.2019; 14(8): e0221650.     CrossRef
• Sex-related Alterations of Gut Microbiota in the C57BL/6 Mouse Model of Inflammatory Bowel Disease
  Hee Jin Son, Nayoung Kim, Chin-Hee Song, Ryoung Hee Nam, Soo In Choi, Joo Sung Kim, Dong Ho Lee
  Journal of Cancer Prevention.2019; 24(3): 173.     CrossRef